Johnson & Johnson

NYSE: JNJHealthcare / Drug Manufacturers - Major / USA
141.86+1.41+1.00%Vol 677 1311Y Perf 16.27%
Jun 20th, 2019 09:53
BID141.86 ASK141.89
Open141.25 Previous Close140.45
Pre-Market141.00 After-Trading140.50
 0.55 0.39%  0.05 0.04%
Target Price
147.15 
Analyst Rating
Moderate Buy 2.14
Potencial %
3.78 
Finscreener Ranking
★★     45.61
Insiders Trans % 3/6/12M
-/-/-57 
Value Ranking
★★+     48.81
Insiders Value % 3/6/12M
-/-/-99 
Growth Ranking
★★★+     56.31
Insiders Shares Cnt. % 3/6/12M
-/-/-99 
Income Ranking
★★+     47.25
Market Cap (mil)376 646 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
75.31 
Earnings Date
16th Jul 2019

Today's Price Range

141.00141.95

52wk Range

120.11148.99

5 Year PE Ratio Range

14.30310.40

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
1.47%
3 Months
2.30%
6 Months
9.50%
1 Year
16.27%
3 Years
21.32%
5 Years
39.20%

Name / TickerPriceChg.Chg.%
JNJ141.861.41001.00
AAPL199.751.88000.95
GOOG1 113.5211.19001.02
MSFT137.291.60001.18
XOM76.651.33001.77
WFC45.36-0.2900-0.64
FB189.602.12001.13
GE10.520.18001.74
JPM109.70-0.2100-0.19
Earnings HistoryEstimateReportedSurprise %
Q01 20192.032.103.45
Q04 20181.951.971.03
Q03 20182.032.050.99
Q02 20182.062.101.94
Q01 20182.012.062.49
Q04 20171.721.741.16
Q03 20171.801.905.56
Q02 20171.791.832.23
Earnings Per EndEstimateRevision %Trend
6/2019 QR2.425.22Positive
9/2019 QR2.05-5.09Negative
12/2019 FY8.600.23Positive
12/2020 FY9.17-0.65Negative
Next Report Date16th Jul 2019
Estimated EPS Next Report2.42
Estimates Count7
EPS Growth Next 5 Years %6.70
Volume Overview
Volume677 131
Shares Outstanding (in ths.)2 655 056
Trades Count2 367
Dollar Volume83 632 201
Avg. Volume6 840 348
Avg. Weekly Volume5 156 566
Avg. Monthly Volume7 767 932
Avg. Quarterly Volume6 500 729
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (35.71 %)
5 (35.71 %)
4 (30.77 %)
Moderate Buy
2 (14.29 %)
2 (14.29 %)
2 (15.38 %)
Hold
7 (50.00 %)
7 (50.00 %)
7 (53.85 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.14
Moderate Buy
2.14
Moderate Buy
2.23

Johnson & Johnson

Johnson & Johnson is the world's largest and most diverse healthcare company. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, close to half of total revenue is generated in the United States.

CEO: Alex Gorsky

Teplephone: +1 732 524-0400

Address: One Johnson & Johnson Plaza, New Brunswick 08933, NJ, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

49%51%

Bearish Bullish

53%47%

Bearish Bullish

60%40%

News